Danaher Pre-Paid Expenses 2010-2025 | DHR
Danaher pre-paid expenses from 2010 to 2025. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
- Danaher pre-paid expenses for the quarter ending March 31, 2025 were $1.494B, a 13.44% increase year-over-year.
- Danaher pre-paid expenses for 2024 were $1.552B, a 0.32% decline from 2023.
- Danaher pre-paid expenses for 2023 were $1.557B, a 10.57% decline from 2022.
- Danaher pre-paid expenses for 2022 were $1.741B, a 4.63% increase from 2021.
| Danaher Annual Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2024 | $1,552 |
| 2023 | $1,557 |
| 2022 | $1,741 |
| 2021 | $1,664 |
| 2020 | $1,430 |
| 2019 | $865 |
| 2018 | $858 |
| 2017 | $857 |
| 2016 | $806 |
| 2015 | $890 |
| 2014 | $953 |
| 2013 | $763 |
| 2012 | $828 |
| 2011 | $904 |
| 2010 | $1,169 |
| 2009 | $589 |
| Danaher Quarterly Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,494 |
| 2024-12-31 | $1,552 |
| 2024-09-30 | $1,248 |
| 2024-06-30 | $1,266 |
| 2024-03-31 | $1,317 |
| 2023-12-31 | $1,557 |
| 2023-09-30 | $1,703 |
| 2023-06-30 | $1,504 |
| 2023-03-31 | $1,457 |
| 2022-12-31 | $1,741 |
| 2022-09-30 | $1,455 |
| 2022-06-30 | $1,461 |
| 2022-03-31 | $1,474 |
| 2021-12-31 | $1,664 |
| 2021-09-30 | $1,293 |
| 2021-06-30 | $1,420 |
| 2021-03-31 | $1,309 |
| 2020-12-31 | $1,430 |
| 2020-09-30 | $936 |
| 2020-06-30 | $833 |
| 2020-03-31 | $767 |
| 2019-12-31 | $865 |
| 2019-09-30 | $611 |
| 2019-06-30 | $633 |
| 2019-03-31 | $733 |
| 2018-12-31 | $858 |
| 2018-09-30 | $702 |
| 2018-06-30 | $732 |
| 2018-03-31 | $810 |
| 2017-12-31 | $857 |
| 2017-09-30 | $465 |
| 2017-06-30 | $524 |
| 2017-03-31 | $715 |
| 2016-12-31 | $806 |
| 2016-09-30 | $728 |
| 2016-06-30 | $898 |
| 2016-03-31 | $974 |
| 2015-12-31 | $890 |
| 2015-09-30 | $852 |
| 2015-06-30 | $835 |
| 2015-03-31 | $919 |
| 2014-12-31 | $953 |
| 2014-09-30 | $592 |
| 2014-06-30 | $660 |
| 2014-03-31 | $719 |
| 2013-12-31 | $763 |
| 2013-09-30 | $690 |
| 2013-06-30 | $714 |
| 2013-03-31 | $775 |
| 2012-12-31 | $828 |
| 2012-09-30 | $500 |
| 2012-06-30 | $542 |
| 2012-03-31 | $614 |
| 2011-12-31 | $904 |
| 2011-09-30 | $852 |
| 2011-06-30 | $839 |
| 2011-03-31 | $1,043 |
| 2010-12-31 | $1,169 |
| 2010-09-30 | $548 |
| 2010-06-30 | $547 |
| 2010-03-31 | $565 |
| 2009-12-31 | $589 |
| 2009-09-30 | $655 |
| 2009-06-30 | $713 |
| 2009-03-31 | $680 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $148.115B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $75.901B | 9.43 |
| Elevance Health (ELV) | United States | $65.016B | 8.74 |
| Cencora (COR) | United States | $56.164B | 19.54 |
| DiDi Global (DIDIY) | China | $25.650B | 27.25 |
| Labcorp Holdings (LH) | United States | $21.906B | 17.29 |
| Natera (NTRA) | United States | $18.548B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.156B | 0.00 |
| ICON (ICLR) | Ireland | $14.957B | 14.39 |
| CochLear (CHEOY) | Australia | $13.609B | 0.00 |
| Solventum (SOLV) | United States | $12.725B | 13.47 |
| Medpace Holdings (MEDP) | United States | $12.583B | 33.30 |
| Revvity (RVTY) | United States | $11.135B | 19.32 |
| Viatris (VTRS) | United States | $10.786B | 3.71 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.074B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.765B | 17.17 |
| HealthEquity (HQY) | United States | $8.282B | 36.28 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.001B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.183B | 30.52 |
| Amplifon S.p.A (AMFPF) | Italy | $5.058B | 27.69 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.446B | 19.58 |
| Surgery Partners (SGRY) | United States | $2.862B | 37.22 |
| Organon (OGN) | United States | $2.636B | 2.80 |
| GeneDx Holdings (WGS) | United States | $2.619B | 60.38 |
| Concentras Parent (CON) | United States | $2.589B | 14.96 |
| Alignment Healthcare (ALHC) | United States | $2.331B | 0.00 |
| Progyny (PGNY) | United States | $1.957B | 43.08 |
| PACS (PACS) | United States | $1.757B | 0.00 |
| Premier (PINC) | United States | $1.749B | 13.27 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Ardent Health (ARDT) | United States | $1.532B | 6.53 |
| Teladoc Health (TDOC) | United States | $1.321B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.192B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.799B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.740B | 6.93 |
| CareDx (CDNA) | United States | $0.708B | 11.06 |
| Embecta (EMBC) | United States | $0.628B | 4.23 |
| So-Young (SY) | China | $0.507B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.489B | 0.00 |
| Nutex Health (NUTX) | United States | $0.474B | 7.18 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| Omada Health (OMDA) | $0.468B | 0.00 | |
| LifeMD (LFMD) | United States | $0.464B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.456B | 10.27 |
| SBC Medicals (SBC) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.401B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.323B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.276B | 0.00 |
| Beauty Health (SKIN) | United States | $0.213B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |